Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8655)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2023 (publication date) through Dec 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Lahtinen P, Jalanka J, Mattila E, Tillonen J, Bergman P, Satokari R, Arkkila P. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial. World J Gastroenterol 2023; 29(17): 2666-2678 [PMID: 37213403 DOI: 10.3748/wjg.v29.i17.2666] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Lahtinen P, Jalanka J, Mattila E, Tillonen J, Bergman P, Satokari R, Arkkila P. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial. World J Gastroenterol 2023; 29(17): 2666-2678 [PMID: 37213403 DOI: 10.3748/wjg.v29.i17.2666] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i17/2666.htm |
| Number | Citing Articles |
| 1 |
Lukas Bethlehem, Maria Manuela Estevinho, Ari Grinspan, Fernando Magro, Jeremiah J Faith, Jean-Frederic Colombel. Microbiota therapeutics for inflammatory bowel disease: the way forward. The Lancet Gastroenterology & Hepatology 2024; 9(5): 476 doi: 10.1016/S2468-1253(23)00441-7
|
| 2 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|
| 3 |
Samira Saedi, Safoura Derakhshan, Javid Sadeghi, Alka Hasani, Manouchehr Khoshbaten, Vahdat Poortahmasebi, Somayeh Ahmadi. A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran. Letters in Applied Microbiology 2025; 78(8) doi: 10.1093/lambio/ovaf111
|
| 4 |
Daphne Moutsoglou, Pavithra Ramakrishnan, Byron P. Vaughn. Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights. Gut Microbes 2025; 17(1) doi: 10.1080/19490976.2025.2477255
|
| 5 |
Shaohan Luo, Mingmin Pan, Gaoshuang Fu, Xiaoying Meng, Ziwei Zhao, Huijie Yu, Guangxin Yue, Tong Lei. Vagus nerve and brain–gut communication in neurodegenerative diseases: Mechanism and therapeutic perspectives. Pharmacological Research 2025; 221: 107974 doi: 10.1016/j.phrs.2025.107974
|
| 6 |
Zhaoyu Zheng, Wenqin Jin, Weiwei Guo, Zhao Jin, Yuling Zuo. Oral Fusobacterium nucleatum exacerbates ulcerative colitis via the oral-gut axis: mechanisms and therapeutic implications. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1564169
|
| 7 |
Dai Ishikawa, Xiaochen Zhang, Kei Nomura, Akihito Nagahara. Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Where We Stand and What Is Next. Inflammatory Intestinal Diseases 2025; 10(1): 371 doi: 10.1159/000549227
|
| 8 |
Jessica Cao, Rebecca Meltzer, Ellen Cohn, Andrew Benjamin, Robert Keskey, John Alverdy. Friend or foe: the gut microbiota as a modulator of disease trajectory in trauma, surgery, and critical illness. Gut Microbes 2025; 17(1) doi: 10.1080/19490976.2025.2552346
|
| 9 |
Andrea R. Merchak, MacKenzie L. Bolen, Malú Gámez Tansey, Kelly B. Menees. Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease. Neurotherapeutics 2024; 21(6): e00476 doi: 10.1016/j.neurot.2024.e00476
|
| 10 |
EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION IN TREATING GASTROINTESTINAL DISEASES: A SYSTEMATIC REVIEW OF EVIDENCE IN CDI, UC, IBS, AND CROHN’S DISEASE. International Journal of Innovative Technologies in Social Science 2025; 6(3(47)) doi: 10.31435/ijitss.3(47).2025.3752
|
| 11 |
Panagiotis G. Doukas, Sotirios G. Doukas, Arkady Broder. Effectiveness and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis Treatment: A Systematic Review and Meta-Analysis. Digestive Diseases 2025; : 1 doi: 10.1159/000548568
|
| 12 |
Rami Khalaf, Martina Sciberras, Pierre Ellul. The role of the fecal microbiota in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2024; 36(11): 1249 doi: 10.1097/MEG.0000000000002818
|
| 13 |
Xiaotao Zhang, Ying Li, Yueyue Guo, Jia Sun, Yang Yang. Clinical efficacy of fecal microbiota transplantation in alleviating depressive symptoms: a meta-analysis of randomized trials. Frontiers in Psychiatry 2025; 16 doi: 10.3389/fpsyt.2025.1656969
|
| 14 |
Loris R Lopetuso, Sara Deleu, Pierluigi Puca, Maria Teresa Abreu, Alessandro Armuzzi, Giovanni Barbara, Flavio Caprioli, Siew Chieng, Samuel Paul Costello, Andrea Damiani, Silvio Danese, Federica Del Chierico, Geert D’Haens, Iris Dotan, Federica Facciotti, Gwen Falony, Massimo Claudio Fantini, Gionata Fiorino, Paolo Gionchetti, Lihi Godny, Ailsa Hart, Juozas Kupčinskas, Tariq Iqbal, Lucrezia Laterza, Letizia Lombardini, Nitsan Maharshak, Giovanni Marasco, Luca Masucci, Alfredo Papa, Sudarshan Paramsothy, Valentina Petito, Daniele Piovani, Daniela Pugliese, Lorenza Putignani, Jeroen Raes, Davide Giuseppe Ribaldone, Maurizio Sanguinetti, Edoardo Vincenzo Savarino, Harry Sokol, Stefania Vetrano, Gianluca Ianiro, Giovanni Cammarota, Fabio Cominelli, Theresa T Pizarro, Herbert Tilg, Antonio Gasbarrini, Severine Vermeire, Franco Scaldaferri. Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference. Inflammatory Bowel Diseases 2025; 31(9): 2408 doi: 10.1093/ibd/izaf013
|
| 15 |
Jonathan A. Montrose, Satya Kurada, Monika Fischer. Current and future microbiome-based therapies in inflammatory bowel disease. Current Opinion in Gastroenterology 2024; 40(4): 258 doi: 10.1097/MOG.0000000000001027
|
| 16 |
Johana Coronel, Marco Toc, Justin Guice, Anne Raggio, Michael J. Keenan, Frank Greenway, Diana Coulon, Jack N. Losso. Whole Montmorency Tart Cherry Smoothie Improves Disease Activity Index in Rat Model of DSS-Induced Ulcerative Colitis by Downregulating the Janus Kinase 1 and Interleukin-17A. Journal of Medicinal Food 2025; 28(12): 1175 doi: 10.1177/1096620X251383878
|
| 17 |
Umang Arora, Saurabh Kedia, Vineet Ahuja. The practice of fecal microbiota transplantation in inflammatory bowel disease. Intestinal Research 2024; 22(1): 44 doi: 10.5217/ir.2023.00085
|
| 18 |
Malik Kasapoglu, Rajesh Yadavalli, Sarosh Nawaz, Abdulaziz Althwanay, Esraa M AlEdani, Harleen Kaur, Samia Butt. The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review. Cureus 2024; doi: 10.7759/cureus.60786
|
| 19 |
Yue Yin, Weibo Feng, Xilang Chen, Jie Chen, Guodong Wang, Limin Xia, Kaichun Wu. Intestinal microecology dysbiosis in inflammatory bowel disease: Pathogenesis and therapeutic strategies. The Innovation Medicine 2024; 2(4): 100092 doi: 10.59717/j.xinn-med.2024.100092
|
| 20 |
Tao Zhang, Xiaoang Li, Jun Li, Feng Sun, Liping Duan. Gut microbiome‐targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta‐analysis. Journal of Gastroenterology and Hepatology 2025; 40(1): 78 doi: 10.1111/jgh.16795
|
| 21 |
Junyi Bai, Ying Wang, Fuhao Li, Yueyao Wu, Jun Chen, Meng Li, Xi Wang, Bin Lv. Research advancements and perspectives of inflammatory bowel disease: A comprehensive review. Science Progress 2024; 107(2) doi: 10.1177/00368504241253709
|
| 22 |
Jee Young Lee, Yehwon Kim, Jiyoun Kim, Jiyeun Kate Kim. Fecal Microbiota Transplantation: Indications, Methods, and Challenges. Journal of Microbiology 2024; 62(12): 1057 doi: 10.1007/s12275-024-00184-3
|
| 23 |
Xueyi Qian, Hua Jiang, Yao Wu, Huimin Shao, Weijie He, Yinmei He, Xin Bao, Lianjun He, Yuliang Jia, Zhenyu Xu. Fecal Microbiota Transplantation Combined with Prebiotics Ameliorates Ulcerative Colitis in Mice. Future Microbiology 2023; 18(17): 1251 doi: 10.2217/fmb-2023-0001
|
| 24 |
Zixuan Cao, Tingting Gao, Ousman Bajinka, Yali Zhang, Xingxing Yuan. Fecal microbiota transplantation-current perspective on human health. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1523870
|
| 25 |
Siyuan Bu, Xiaozhen Cheng, Meng Chen, Yongduo Yu. Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategies. Pharmacogenomics and Personalized Medicine 2025; : 219 doi: 10.2147/PGPM.S536459
|
| 26 |
Huanyu Li, Meng Pan, Yifan Li, Manli Cui, Mingxin Zhang. New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites. Computational and Structural Biotechnology Journal 2025; 27: 1850 doi: 10.1016/j.csbj.2025.05.006
|
| 27 |
R. Gefen, J. Dourado, S. H. Emile, A. Wignakumar, P. Rogers, P. Aeschbacher, Z. Garoufalia, N. Horesh, S. D. Wexner. Fecal microbiota transplantation for patients with ulcerative colitis: a systematic review and meta-analysis of randomized control trials. Techniques in Coloproctology 2025; 29(1) doi: 10.1007/s10151-025-03113-7
|
| 28 |
Connor Prosty, Khaled Katergi, Jesse Papenburg, Alexander Lawandi, Todd C Lee, Hao Shi, Philip Burnham, Lee Swem, Bertrand Routy, Cedric P Yansouni, Matthew P Cheng. Causal role of the gut microbiome in certain human diseases: a narrative review. eGastroenterology 2024; 2(3): e100086 doi: 10.1136/egastro-2024-100086
|
| 29 |
Jing Jia, Yun-bo Wu, Si-wei Liu, Wei-jing Chen, Ru-liu Li, Yun-long Bai, Ling Hu. Effectiveness and safety of non-pharmacological therapies for the treatment of inflammatory bowel disease: a network meta-analysis. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1593483
|
| 30 |
Benjamin H Mullish, Blair Merrick, Mohammed Nabil Quraishi, Aggie Bak, Christopher A Green, David J Moore, Robert J Porter, Ngozi T Elumogo, Jonathan P Segal, Naveen Sharma, Belinda Marsh, Graziella Kontkowski, Susan E Manzoor, Ailsa L Hart, Christopher Settle, Josbert J Keller, Peter Hawkey, Tariq H Iqbal, Simon D Goldenberg, Horace R T Williams.
The use of faecal microbiota transplant as treatment for recurrent or refractory
Clostridioides difficile
infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
. Gut 2024; 73(7): 1 doi: 10.1136/gutjnl-2023-331550
|
| 31 |
B.H. Mullish, B. Merrick, M.N. Quraishi, A. Bak, C.A. Green, D.J. Moore, R.J. Porter, N.T. Elumogo, J.P. Segal, N. Sharma, B. Marsh, G. Kontkowski, S.E. Manzoor, A.L. Hart, C. Settle, J.J. Keller, P. Hawkey, T.H. Iqbal, S.D. Goldenberg, H.R.T. Williams. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Journal of Hospital Infection 2024; 148: 189 doi: 10.1016/j.jhin.2024.03.001
|
| 32 |
Walaa K. Mousa, Aya Al Ali. The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2024; 25(20): 11259 doi: 10.3390/ijms252011259
|
| 33 |
Rohan Singhal, Gayatri Ghadvaje, Nanditha Karra, Sai Teja Gadde, Prerna Chandra, Bharat Krishna Teja Voruganti, Navya Pillikunte Doddareddy, Sadaf Iftikhar, Tirath Patel. A narrative review on fecal microbiota transplantation routes in ulcerative colitis: identifying the optimal approach across key parameters. Annals of Medicine & Surgery 2025; 87(10): 6599 doi: 10.1097/MS9.0000000000003841
|
| 34 |
Thabit Moath Omar, Karar H. Alfarttoosi, Gaurav Sanghvi, R. Roopashree, Aditya Kashyap, T. Krithiga, Waam Mohammed Taher, Mariem Alwan, Mahmood Jasem Jawad, Ali M. Ali Al-Nuaimi. Engineering the Microbiome: a Novel Approach to Managing Autoimmune Diseases. NeuroMolecular Medicine 2025; 27(1) doi: 10.1007/s12017-025-08879-5
|